Gregory Mark Weinhoff
Director of Finance/CFO chez CENTESSA PHARMACEUTICALS PLC
Fortune : 3 M $ au 31/03/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Mark F. Altmeyer | M | 63 |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY.
Arvelle Therapeutics International GmbH
 Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | 9 ans |
| Bradley Campbell | M | 48 | 18 ans | |
| Mike Raab Raab | M | 59 | 20 ans | |
| Francesco de Rubertis | M | 54 | 4 ans | |
| Samarth Kulkarni | M | 45 | 3 ans | |
| Saurabh Saha | M | 47 | 3 ans | |
| Antoine Yver | M | 66 | 3 ans | |
| Mary Lynne Hedley | M | 61 | 3 ans | |
| Kristen K. Sheppard | F | - | 2 ans | |
| Brett Zbar | M | 51 | 3 ans | |
| Otto Schwarz | M | 68 |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | 5 ans |
| Carol Stuckley | F | 68 | 3 ans | |
| Tim F. Howe | M | 66 |
Healthinvest Equity Partners
 Healthinvest Equity Partners Investment ManagersFinance Healthinvest Equity Partners (Healthinvest Equity) is a venture capital firm founded in 2013 by Wilfred Jaeger M.D. The firm is headquartered in Westport, Connecticut. | 11 ans |
| Mathias Hukkelhoven | M | 70 | 2 ans | |
| Glenn Sblendorio | M | 68 | 18 ans | |
| Wilfred Jaeger | M | 67 |
Healthinvest Equity Partners
Healthinvest Equity Partners Investment ManagersFinance Healthinvest Equity Partners (Healthinvest Equity) is a venture capital firm founded in 2013 by Wilfred Jaeger M.D. The firm is headquartered in Westport, Connecticut. | 11 ans |
| David Chao | M | 56 | 3 ans | |
| Patrick Yue | M | - | 1 ans | |
| Iqbal Hussain | M | 43 | 3 ans | |
| Harris Rotman | M | - | 2 ans | |
| April Dovholuk | M | - | 1 ans | |
| Pomjin Choi | M | - |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | - |
| David L. Steffy | M | 80 |
Healthinvest Equity Partners
Healthinvest Equity Partners Investment ManagersFinance Healthinvest Equity Partners (Healthinvest Equity) is a venture capital firm founded in 2013 by Wilfred Jaeger M.D. The firm is headquartered in Westport, Connecticut. | - |
| Michael Bologna | M | - |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | - |
| Jeong-Woo Jo | M | - |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | 5 ans |
| Arjun Goyal | M | - | 3 ans | |
| Karen Anderson | F | 57 | 2 ans | |
| Alex Zisson | M | 54 |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | - |
| Myles D. Greenberg | M | 56 |
Healthinvest Equity Partners
Healthinvest Equity Partners Investment ManagersFinance Healthinvest Equity Partners (Healthinvest Equity) is a venture capital firm founded in 2013 by Wilfred Jaeger M.D. The firm is headquartered in Westport, Connecticut. | - |
| Martijn Kleijwegt | M | 69 |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | 5 ans |
| Jeff J. Collinson | M | - |
Healthinvest Equity Partners
Healthinvest Equity Partners Investment ManagersFinance Healthinvest Equity Partners (Healthinvest Equity) is a venture capital firm founded in 2013 by Wilfred Jaeger M.D. The firm is headquartered in Westport, Connecticut. | - |
| Jeffrey Castelli | M | - | 19 ans | |
| Ellie Im | M | - | 1 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Daphne Quimi | F | 58 | 18 ans | |
| Pavan Cheruvu | M | 42 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 4 ans |
| John Crowley | M | 57 | 22 ans | |
| Vivek Ramaswamy | M | 38 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 3 ans |
| David Hung | M | 66 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 1 ans |
| Ilise Lombardo | M | - |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | 4 ans |
| Alan S. Roemer | M | 54 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | - |
| Donald Hayden | M | 68 | 12 ans | |
| John M. McAdam | M | 49 | 4 ans | |
| Parag V. Meswani | M | - | 4 ans | |
| Thomas S. Templeman | M | 64 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 4 ans |
| Douglas A. Branch | M | - | - | |
| Matt Patterson | M | 52 | 6 ans | |
| Gavin R. Corcoran | M | 61 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 3 ans |
| Samina Bari | M | - | - | |
| Mohan Ganesan | M | 56 | 4 ans | |
| Aaron Kantoff | M | 29 | 1 ans | |
| Ann Thorell | F | 56 | 1 ans | |
| S. Schaeffer | F | 55 | 7 ans | |
| Ilan Oren | M | 40 | 5 ans | |
| David Palling | M | 70 | - | |
| Christine Cvijic | F | 46 | 2 ans | |
| Tony Vernon | M | 68 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 1 ans |
| Geoffrey P. Gilmore | M | 58 | 4 ans | |
| Marion McCourt | F | 64 | 1 ans | |
| James Topper | M | 62 | 11 ans | |
| Clarence Machado | M | 60 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 1 ans |
| Senthil Sundaram | M | 46 | 4 ans | |
| Alexander E. Barkas | M | 76 | - | |
| Lawrence Olanoff | M | 72 | 2 ans | |
| George Bickerstaff | M | 68 | 2 ans | |
| Sol Barer | M | 76 | 8 ans | |
| Kenneth W. Peist | M | 60 | 4 ans | |
| Gary Pisano | M | 62 | 1 ans | |
| Javad Shahidi | M | - | - | |
| Matt Bullard | M | - |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | 1 ans |
| Gregory MacMichael | M | 68 | 1 ans | |
| Peter Lee | M | 48 |
J.H. Whitney Capital Partners, LLC
 J.H. Whitney Capital Partners, LLC Investment ManagersFinance J. H. Whitney & Co. LLC operates as an alternative investment manager. The firm provides private equity capital to small and middle market companies. The company was founded by John Hay Whitney in 1946 and is headquartered in New Canaan, CT. | 2 ans |
| Michael Adasczik | M | 50 | 3 ans | |
| Heather White | F | - | - | |
| Eric Floyd | M | 62 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 2 ans |
| Jonathan Atkeson | M | 51 |
J.H. Whitney Capital Partners, LLC
J.H. Whitney Capital Partners, LLC Investment ManagersFinance J. H. Whitney & Co. LLC operates as an alternative investment manager. The firm provides private equity capital to small and middle market companies. The company was founded by John Hay Whitney in 1946 and is headquartered in New Canaan, CT. | 3 ans |
| Matt Q. Reber | M | - |
J.H. Whitney Capital Partners, LLC
J.H. Whitney Capital Partners, LLC Investment ManagersFinance J. H. Whitney & Co. LLC operates as an alternative investment manager. The firm provides private equity capital to small and middle market companies. The company was founded by John Hay Whitney in 1946 and is headquartered in New Canaan, CT. | - |
| Bruce Ganem | M | - | 4 ans | |
| David J. Lockhart | M | 62 | 7 ans | |
| Robert G. Warden | M | 51 |
J.H. Whitney Capital Partners, LLC
J.H. Whitney Capital Partners, LLC Investment ManagersFinance J. H. Whitney & Co. LLC operates as an alternative investment manager. The firm provides private equity capital to small and middle market companies. The company was founded by John Hay Whitney in 1946 and is headquartered in New Canaan, CT. | 3 ans |
| Andrew Shenker | M | 69 | - | |
| Pol Boudes | M | 67 | 4 ans | |
| Kenneth J. Valenzano | M | 56 | - | |
| Norman Hardman | M | 78 | 2 ans | |
| Myrtle Potter | F | 65 | 2 ans | |
| Kathryn Falberg | F | 63 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 1 ans |
| Joseph Michael Warusz | M | 67 | 1 ans | |
| J. Ryan Kelly | M | - |
J.H. Whitney Capital Partners, LLC
J.H. Whitney Capital Partners, LLC Investment ManagersFinance J. H. Whitney & Co. LLC operates as an alternative investment manager. The firm provides private equity capital to small and middle market companies. The company was founded by John Hay Whitney in 1946 and is headquartered in New Canaan, CT. | 3 ans |
| Jacqualyn Fouse | M | 62 | - | |
| John R. Kirk | M | 67 | - | |
| Gregory Licholai | M | 59 | 5 ans | |
| Joshua D. Hamermesh | M | 51 | - | |
| Dan Kittredge | M | - |
J.H. Whitney Capital Partners, LLC
J.H. Whitney Capital Partners, LLC Investment ManagersFinance J. H. Whitney & Co. LLC operates as an alternative investment manager. The firm provides private equity capital to small and middle market companies. The company was founded by John Hay Whitney in 1946 and is headquartered in New Canaan, CT. | 2 ans |
| James Dentzer | M | 57 | 3 ans | |
| Matt Wilson | M | 48 |
J.H. Whitney Capital Partners, LLC
J.H. Whitney Capital Partners, LLC Investment ManagersFinance J. H. Whitney & Co. LLC operates as an alternative investment manager. The firm provides private equity capital to small and middle market companies. The company was founded by John Hay Whitney in 1946 and is headquartered in New Canaan, CT. | 2 ans |
| Lawrence T. Friedhoff | M | 75 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | - |
| Olivier Litzka | M | 56 |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | - |
| Frank Torti | M | 45 | 5 ans | |
| Alexander Pasteur | M | 54 |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | 1 ans |
| David Grainger | M | 58 | 3 ans | |
| petra Molan | F | - |
Arvelle Therapeutics BV
 Arvelle Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Arvelle Therapeutics BV is a Dutch biopharmaceutical company that focuses on providing innovative solutions to patients with CNS disorders. The private company is responsible for developing and commercializing an investigational anti-seizure medicine called Cenobamate in the European market. Arvelle received start-up financing of $207.80 million, which is one of the largest initial financing commitments for a European-focused biopharmaceutical company. The company is headquartered in Amsterdam, Netherlands. Arvelle was founded by Gregory Mark Weinhoff and Mark F. Altmeyer, and Mark F. Altmeyer has been the CEO since incorporation. | 2 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 68 | 68,00% |
| Royaume-Uni | 23 | 23,00% |
| Suisse | 11 | 11,00% |
| Pays-Bas | 1 | 1,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Gregory Mark Weinhoff
- Réseau Personnel
